Greenbrook TMS - GBNH Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $7.06
  • Forecasted Upside: 242.82 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$2.06
▼ -0.12 (-5.50%)

This chart shows the closing price for GBNH by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Greenbrook TMS Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for GBNH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for GBNH

Analyst Price Target is $7.06
▲ +242.82% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Greenbrook TMS in the last 3 months. The average price target is $7.06, with a high forecast of $11.00 and a low forecast of $4.50. The average price target represents a 242.82% upside from the last price of $2.06.

This chart shows the closing price for GBNH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 2 investment analysts is to buy stock in Greenbrook TMS.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/11/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/9/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/8/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/8/2022
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/6/2022
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/4/2022
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/3/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/3/2022

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/10/2022Canaccord Genuity GroupLower TargetC$6.25 ➝ C$4.75Low
10/19/2022Stifel NicolausLower TargetC$8.75 ➝ C$8.00Low
7/20/2022Lake Street CapitalLower Target$13.00 ➝ $11.00Low
7/18/2022Canaccord Genuity GroupLower TargetBuy ➝ BuyC$7.50 ➝ C$6.25Low
7/18/2022Clarus SecuritiesLower TargetC$7.50 ➝ C$4.50Low
5/17/2022Stifel NicolausLower TargetC$19.00 ➝ C$10.00Low
4/4/2022Bloom BurtonReiterated RatingBuyLow
4/4/2022Clarus SecuritiesLower TargetC$8.25 ➝ C$7.50Low
2/7/2022Canaccord Genuity GroupDowngradeBuyLow
11/23/2021DesjardinsLower TargetBuyC$20.00 ➝ C$18.50Low
11/11/2021Stifel NicolausLower TargetBuyC$22.00 ➝ C$19.00High
11/11/2021Clarus SecuritiesLower TargetAverage ➝ BuyC$26.00 ➝ C$23.75High
11/11/2021DesjardinsReiterated RatingBuyC$20.00High
10/5/2021Lake Street CapitalInitiated CoverageBuy$17.00High
10/5/2021Bloom BurtonReiterated RatingBuy$16.00Medium
9/30/2021Clarus SecuritiesReiterated RatingSpeculative BuyMedium
7/8/2021DesjardinsInitiated CoverageBuyHigh
4/9/2021Bloom BurtonReiterated RatingBuy$16.00Low
(Data available from 12/4/2017 forward)

News Sentiment Rating

0.50 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/8/2022
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/7/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/7/2022
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/6/2022
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/5/2022
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/5/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/4/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/4/2022

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Greenbrook TMS logo
Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, as well as related psychiatric services. As of December 31, 2021, the company operated 94 wholly owned and 55 TMS centers in the commonwealth of Virginia and the States of Maryland, Delaware, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, South Carolina, Michigan, Alaska, Oregon, California, Iowa, and Massachusetts. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.
Read More

Today's Range

Now: $2.06
Low: $2.06
High: $2.17

50 Day Range

MA: $2.90
Low: $2.06
High: $3.81

52 Week Range

Now: $2.06
Low: $1.27
High: $5.92

Volume

2,383 shs

Average Volume

5,316 shs

Market Capitalization

$36.67 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.77

Frequently Asked Questions

What sell-side analysts currently cover shares of Greenbrook TMS?

The following sell-side analysts have issued reports on Greenbrook TMS in the last twelve months: Bloom Burton, Canaccord Genuity Group Inc., Clarus Securities, Lake Street Capital, and Stifel Nicolaus.
View the latest analyst ratings for GBNH.

What is the current price target for Greenbrook TMS?

4 Wall Street analysts have set twelve-month price targets for Greenbrook TMS in the last year. Their average twelve-month price target is $7.06, suggesting a possible upside of 242.8%. Lake Street Capital has the highest price target set, predicting GBNH will reach $11.00 in the next twelve months. Clarus Securities has the lowest price target set, forecasting a price of $4.50 for Greenbrook TMS in the next year.
View the latest price targets for GBNH.

What is the current consensus analyst rating for Greenbrook TMS?

Greenbrook TMS currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe GBNH will outperform the market and that investors should add to their positions of Greenbrook TMS.
View the latest ratings for GBNH.

What other companies compete with Greenbrook TMS?

How do I contact Greenbrook TMS's investor relations team?

Greenbrook TMS's physical mailing address is 890 YONGE STREET 7TH FLOOR, TORONTO A6, M4W 3P4. The company's listed phone number is (416) 915-9100 and its investor relations email address is [email protected] The official website for Greenbrook TMS is www.greenbrooktms.com. Learn More about contacing Greenbrook TMS investor relations.